Parkinson's disease is one of a number of neurodegenerative diseases caused when naturally occurring proteins fold into the wrong shape and stick together with other proteins, eventually forming thin filament-like structures called amyloid fibrils. These amyloid deposits of aggregated alpha-synuclein, also known as Lewy bodies, are the hallmark of Parkinson's disease.
Researchers have used a non-invasive method of observing how the process leading to Parkinson's disease takes place at the nanoscale, and identified the point in the process at which proteins in the brain become toxic, eventually leading to the death of brain cells.
The results suggest that the same protein can either cause, or protect against, the toxic effects that lead to the death of brain cells, depending on the specific structural form it takes, and that toxic effects take hold when there is an imbalance of the level of protein in its natural form in a cell. The study is published in the journal Proceedings of the National Academy of Sciences.
Using super-resolution microscopy, researchers from the University of Cambridge were able to observe the behaviour of different types of alpha-synuclein, a protein closely associated with Parkinson's disease, in order to find how it affects neurons, and at what point it becomes toxic.
Researchers have used optical 'super-resolution' techniques to look into live neurons without damaging the tissue. They used different forms of alpha-synuclein and observed their behavior in neurons from rats. They were then able to correlate what they saw with the amount of toxicity that was present.
They found that when they added alpha-synuclein fibrils to the neurons, they interacted with alpha-synuclein protein that was already in the cell, and no toxic effects were present. But when they added a different, soluble form of alpha-synuclein, it didn't interact with the protein that was already present in the neuron and interestingly this was where we saw toxic effects and cells began to die. So somehow, when the soluble protein was added, it created this toxic effect. The damage appears to be done before visible fibrils are even formed."
The researchers then observed that by adding the soluble form of alpha-synuclein together with amyloid fibrils, the toxic effect of the former could be overcome. It appeared that the amyloid fibrils acted like magnets for the soluble protein and mopped up the soluble protein pool, shielding against the associated toxic effects.
"These findings change the way we look at the disease, because the damage to the neuron can happen when there is simply extra soluble protein present in the cell - it's the excess amount of this protein that appears to cause the toxic effects that lead to the death of brain cells," said the author. Extra soluble protein can be caused by genetic factors or ageing, although there is some evidence that it could also be caused by trauma to the head.
Latest News
Gene expression signature t…
By newseditor
Posted 02 Jun
The mechanisms behind swall…
By newseditor
Posted 02 Jun
A new mechanism for sodium…
By newseditor
Posted 02 Jun
How inherited neurodegenera…
By newseditor
Posted 02 Jun
Slowing down muscular dystr…
By newseditor
Posted 02 Jun
Other Top Stories
Multiscale engineered artificial tooth enamel
Read more
How a single nerve cell can do the multiplication?
Read more
Organic Electrochemical Neurons and Synapses with Ion Mediated Spiking
Read more
A neural population selective for song in human auditory cortex
Read more
Increasing sensitivity of X-ray imaging
Read more
Protocols
Protocol to establish a gen…
By newseditor
Posted 03 Jun
Metaboverse enables automat…
By newseditor
Posted 02 Jun
Ratphones: An Affordable To…
By newseditor
Posted 31 May
BigNeuron: A resource to be…
By newseditor
Posted 29 May
Designed active-site librar…
By newseditor
Posted 27 May
Publications
ER proteostasis regulators…
By newseditor
Posted 03 Jun
Gene expression signature p…
By newseditor
Posted 02 Jun
Prox2 and Runx3 vagal senso…
By newseditor
Posted 02 Jun
Insulin detection in diabet…
By newseditor
Posted 02 Jun
A salt stress-activated GSO…
By newseditor
Posted 02 Jun
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar